BridgeBio Pharma (BBIO) PT Lowered to $46 at BMO Capital

March 9, 2020 8:41 AM EDT Send to a Friend

BMO Capital analyst George Farmer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BridgeBio Pharma (BBIO) PT Lowered to $46 at BMO Capital

Member Login

Free News Feed